Searched for
EMCURE PHARMA LISTING
PE investor BC Investments sells Rs 612 crore stake in Emcure Pharma; Kotak MF picks up stakePrivate equity firm BC Investments IV sold a Rs 612 crore stake in Emcure Pharmaceuticals to Kotak Mahindra Mutual Fund at Rs 1,700 per sha...- Cancer drug makers seek 50% price hike as platinum surge hits production viabilityLocal drug manufacturers are struggling to produce essential cancer medicines like carboplatin and cisplatin due to a significant surge in ...
- Emcure Pharma shares in focus as Bain Capital likely to offload 2.4% stake via block dealBC Investments IV, linked to Bain Capital, is expected to sell a 2.4% stake in Emcure Pharmaceuticals. The sale will occur through a block ...
- Hot Stocks: Jefferies sees over 30% upside in RIL; Emcure gets an upgrade from KotakJefferies emphasizes a strong outlook for Reliance Industries, driven by favorable refining dynamics, robust 5G monetization prospects, and...
- Hot stocks: Brokerage view on Bajaj Auto, Emcure Pharma, LTIMindtree and Bajaj FinanceCLSA maintains an underperform rating on Bajaj Auto with a target price of Rs 7,000. The recent launch of entry-level motorcycles by Bajaj ...
- Emcure Pharma shares jump over 4% post listing. Should you buy, sell or hold?Pune-based Emcure Pharmaceuticals listed at Rs 1,325, a 31.4% premium on Rs 1,008 IPO price. QIBs subscribed 195.8 times, non-institutional...
- Emcure Pharma shares debut with 31% premium over issue priceBefore listing, the company's shares traded at a Rs 360 premium in the grey market. It raised Rs 582 crore from anchor investors, including...
- Namita Thapar-backed Emcure Pharma IPO opens for subscription. Should you bid?Emcure Pharma IPO: Emcure Pharmaceuticals IPO, with marquee investors like Goldman Sachs, offers a fresh equity issuance and OFS. Namita Th...
- Emcure Pharmaceuticals IPO fully subscribed on Day 1. Check GMP and other detailsEmcure Pharmaceuticals' IPO attracts high demand from investors, with a price range of Rs 960-1008 per share. Analysts foresee business imp...
- IPO Analysis: Emcure has better-listed pharma alternativesEmcure Pharma, with its strong presence in gynaecology and HIV therapeutic areas, secured significant investments from anchor investors lik...
- Ola Electric, Emcure Pharma get Sebi nod for IPOs, setting stage for big listingsThe Bengaluru-based company had filed its draft prospectus with Sebi in December last year. The issue comprises a fresh equity sale of Rs 5...
- Emcure Pharma to launch IPO in 3 months: Namita Thapar of Shark Tank fameShark Tank fame and Executive Director of Emcure Pharmaceuticals, Namita Thapar said at the ET NOW Global Business Summit 2024 on February ...
- 5 pharma/healthcare IPOs to raise over Rs 8,000 cr this monthAccording to data available with the stock exchanges, so far this fiscal, 12 firms have raised Rs 27,000 crore from IPOs, and Rs 70,000-cro...
- PEs in talks for Emcure stake; promoters eye $2 billion valuationJM Financial is advising the company for the stake sale.
- Pharma stocks soar despite US lawsuitAmong other listed stocks out of the five, Cadila Healthcare gained 2.87 per cent at Rs 512 at around the same time.
- Emcure Pharmaceuticals acquires Canadian company and its marketing arm MarcanMarcan Pharma has over 60 approved products that are mainly available via McKesson and Kohl & Frisch, among other wholesalers, it claimed.
- Blackstone to sell its stake in Emcure Pharma to Bain CapitalPrivate equity major Blackstone is selling its stake in Pune-based Emcure Pharmaceuticals to Bain Capital.
- Blackstone in talks with Bain Capital to sell 13.09% stake in Emcure PharmaThe deal will mark Blackstone's second exit from its Indian portfolio after it had sold its stake in back-office provider Intelenet to the ...
- Apax, KKR in talks to acquire Blackstone stake in EmcureHealthcare is 1 of the 5 sectors in which Apax Partners invests globally, besides technology & telecom, retail & consumer, media, financial...
- Cos changing diarrhoea syrup formula to evade price controlNext time your child refuses to take the diarohhea syrup, don’t blame the poor kid. The change in the chemical composition of popular paedi...
Load More
